340B Rebate Plan Sparks Questions On Enforcement, Appeals
The Trump administration's plan to test a post-sale rebate model for the 340B drug discount program will require drugmakers to explain why they denied a rebate....To view the full article, register now.
Already a subscriber? Click here to view full article